Unknown

Dataset Information

0

CD40-activated B cells express full lymph node homing triad and induce T-cell chemotaxis: potential as cellular adjuvants.


ABSTRACT: CD40-activated B cells (CD40-B cells) have previously been introduced as an alternative source of antigen-presenting cells for immunotherapy. CD40-B cells can prime naive and expand memory T cells, and they can be generated in large numbers from very small amounts of peripheral blood derived from healthy individuals or cancer patients alike. Administration of CD40-B cells as a cellular adjuvant would require these cells to migrate toward secondary lymphoid organs and attract T cells in situ, processes guided by specific chemokines and chemokine receptors. Here, we demonstrate that primary, human CD40-B cells express a pattern of adhesion molecules and chemokine receptors necessary for homing to secondary lymphoid organs and have the capacity to migrate to cognate ligands. Furthermore, we show that CD40-B cells express important T-cell attractants and induce strong T-cell chemotaxis. These findings further support the use of CD40-B cells as cellular adjuvant for cancer immunotherapy.

SUBMITTER: von Bergwelt-Baildon M 

PROVIDER: S-EPMC1895368 | biostudies-literature | 2006 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

CD40-activated B cells express full lymph node homing triad and induce T-cell chemotaxis: potential as cellular adjuvants.

von Bergwelt-Baildon Michael M   Shimabukuro-Vornhagen Alexander A   Popov Alexey A   Klein-Gonzalez Nela N   Fiore Francesca F   Debey Svenja S   Draube Andreas A   Maecker Britta B   Menezes Isaura I   Nadler Lee M LM   Schultze Joachim L JL  

Blood 20051215 7


CD40-activated B cells (CD40-B cells) have previously been introduced as an alternative source of antigen-presenting cells for immunotherapy. CD40-B cells can prime naive and expand memory T cells, and they can be generated in large numbers from very small amounts of peripheral blood derived from healthy individuals or cancer patients alike. Administration of CD40-B cells as a cellular adjuvant would require these cells to migrate toward secondary lymphoid organs and attract T cells in situ, pro  ...[more]

Similar Datasets

| S-EPMC4497758 | biostudies-literature
| S-EPMC3807207 | biostudies-literature
| S-EPMC4792266 | biostudies-other
| S-EPMC3447002 | biostudies-literature
| S-EPMC336895 | biostudies-other
| S-EPMC2571923 | biostudies-literature
| S-EPMC8560825 | biostudies-literature
| S-EPMC2843821 | biostudies-literature
| S-EPMC5123812 | biostudies-literature